South & Central America Lung Cancer Screening Market Forecast to 2030

South & Central America Lung Cancer Screening Market Forecast to 2030 – Regional Analysis– by Cancer Type [Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography (LDCT), Chest X-Ray, Liquid Biopsy, and Others], Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)

Send Enquiry
Item ID: BMIRE00029065 Category: Tags: , ,

$2,100$3,500

Description

The South & Central America lung cancer screening market is expected to grow from US$ 39.16 million in 2022 to US$ 68.95 million by 2030. It is estimated to grow at a CAGR of 7.3% from 2022 to 2030.

High cost of lung cancer screening tests fuel South & Central America lung cancer screening market.
Amid growing healthcare awareness in the region, lung cancer screening providers in the region has ample opportunities. These include collaborating with regional hospitals and clinics through which they can offer accessible lung cancer screening and leveraging telemedicine for remote areas. This approach not only detects lung cancer early but also improves patient outcomes, filling a crucial gap in the region’s healthcare. By aligning with the rising demand for preventive care, these providers can establish a foothold in a promising market, ultimately contributing to enhanced public health and well-being across the region.

South & Central America Lung Cancer Screening Market Overview

The South & Central America lung cancer screening market is segmented into the Brazil, Argentina, and the Rest of South & Central America. The regional growth is attributed to various factors, such as the increasing incidence of lung cancer and growing awareness of lung cancer screening among people. Also, rising government support for screening has led to the further growth of the market.

The lung cancer screening market is being influenced by factors such as the increasing prevalence of cancer. For instance, as per Globocan 2020 report, lung cancer is Brazil’s second most prevalent cancer. There were 88492 new cases of lung cancer found in Brazil.
Lung cancer screening is believed to be the standard of care worldwide. In Brazil, complications in its implementation related to the organization of the health system, access to CT scans and treatment methods, and cultural acceptance of the method restrict the process. There are challenges and barriers in carrying out the screening according to the local organization; however, it was possible to obtain satisfactory results in all scenarios.

According to Lung Cancer Policy Network, In Brazil, a coordinated approach to lung cancer screening is necessary, as health assistance is fragmented across the country and has resulted in significant health inequalities. The advantages of LDCT screening were recently described in the Second Brazilian Early Lung Cancer Screening Trial (BRELT2). Nevertheless, there are still many barriers to overcome before an organized screening program can be implemented nationwide, including inequitable access to screening equipment between public and private healthcare. To manage this challenge, as part of the Propulmão Mobile Project, the municipal health office in Barretos (São Paulo) collaborated with the local cancer hospital to deliver mobile LDCT screening and a smoking cessation intervention in the community.

South & Central America Lung Cancer Screening Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Lung Cancer Screening Market Segmentation

The South & Central America lung cancer screening market is segmented into cancer type, technology, age group, end user, and country.

Based on cancer type, the South & Central America lung cancer screening market is segmented into non–small cell lung cancer (NSCLC), and small cell lung cancer. The non–small cell lung cancer (NSCLC) segment held a larger share of the South & Central America lung cancer screening market in 2022.

Based on technology, the South & Central America lung cancer screening market is segmented into chest X-ray, low dose computed tomography (LDCT), liquid biopsy, and others. Chest X-ray segment held the largest share of the South & Central America lung cancer screening market in 2022.

Based on age group, the South & Central America lung cancer screening market is segmented into 50 and older, and below 50. 50 and older segment held the larger share of the South & Central America lung cancer screening market in 2022.

Based on end user, the South & Central America lung cancer screening market is segmented into hospital, diagnostic centre, and others. Hospital segment held the largest share of the South & Central America lung cancer screening market in 2022.

Based on country, the South & Central America lung cancer screening market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America lung cancer screening market in 2022.
Siemens AG, Koninklijke Philips NV, Canon Inc, Medtronic, and GE HealthCare technologies Inc are some of the leading companies operating in the South & Central America lung cancer screening market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 7.3% CAGR, the South & Central America Lung Cancer Screening Market is speculated to be worth US$ 68.95 million by 2030, saysthe research team

According tothe research team’ Research, the South & Central America lung cancer screening market was valued at US$ 39.16 million in 2022 and is expected to reach US$ 68.95 million by 2030, registering a CAGR of 7.3% from 2022 to 2030. Rising lung cancer incidences is the critical factor attributed to the South & Central America lung cancer screening market.

One of the dominant trends in the market for lung cancer diagnostics is the use of cutting-edge technologies. Liquid biopsies and genomic profiling will become increasingly popular, allowing for the more accurate and non-invasive detection of cancer-related mutations and biomarkers. By analyzing complicated medical data and images, AI and machine learning will improve diagnostic accuracy and help radiologists spot indications to lung cancer. Additionally, multi-modal approaches that combine different diagnostic modalities for comparative assessment will receive more attention. These developments will result in earlier and more precise diagnoses of lung cancer, enabling prompt interventions and better patient outcomes.

On the contrary, high cost of lung cancer screening hampers the South & Central America lung cancer screening market.

Based on cancer type, the South & Central America lung cancer screening market is segmented into non–small cell lung cancer (NSCLC) and small cell lung cancer. The non–small cell lung cancer (NSCLC) segment held 82.6% share of South & Central America lung cancer screening market in 2022, amassing US$ 32.36 million. It is projected to garner US$ 56.14 million by 2030 to expand at 7.1% CAGR during 2022–2030.

Based on technology, the South & Central America lung cancer screening market is segmented into chest X-ray, low dose computed tomography (LDCT), liquid biopsy, and others. The chest X-ray segment held 42.8% share of South & Central America lung cancer screening market in 2022, amassing US$ 16.78 million. It is projected to garner US$ 29.25 million by 2030 to expand at 7.2% CAGR during 2022–2030.

Based on age group, the South & Central America lung cancer screening market is segmented into 50 and older and below 50. The 50 and older segment held 89.4% share of South & Central America lung cancer screening market in 2022, amassing US$ 35.00 million. It is projected to garner US$ 61.21 million by 2030 to expand at 7.2% CAGR during 2022–2030.

Based on end user, the South & Central America lung cancer screening market is segmented into hospitals, diagnostic centers, and others. The Hospitals segment held 49.9% share of South & Central America lung cancer screening market in 2022, amassing US$ 19.54 million. It is projected to garner US$ 33.32 million by 2030 to expand at 6.9% CAGR during 2022–2030.

Based on country, the South & Central America lung cancer screening market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 66.7% share of South & Central America lung cancer screening market in 2022. It was assessed at US$ 26.13 million in 2022 and is likely to hit US$ 46.88 million by 2030, exhibiting a CAGR of 7.6% during 2022–2030.
Key players operating in the South & Central America lung cancer screening market are GE HealthCare, Medtronic, Canon Inc, Koninklijke Philips NV, and Siemens AG, Inc among others.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Lung Cancer Screening Market – by Technology
1.3.2 South & Central America Lung Cancer Screening Market – by Cancer Type
1.3.3 South & Central America Lung Cancer Screening Market – by Age Group
1.3.4 South & Central America Lung Cancer Screening Market – by End User
1.3.5 South & Central America Lung Cancer Screening Market – by Country
2. South & Central America Lung Cancer Screening Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Lung Cancer Screening Market – Market Landscape
4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. South & Central America Lung Cancer Screening Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Lung Cancer Incidences
5.2 Market Restraints
5.2.1 High Cost of Lung Cancer Screening Tests
5.3 Market Opportunities
5.3.1 Collaboration with Regional Hospitals and Clinics
5.4 Future Trends
5.4.1 Use of Cutting-Edge Technologies
5.5 Impact Analysis
6. Lung Cancer Screening Market – South & Central America Analysis
6.1 South & Central America Lung Cancer Screening Market Revenue Forecast and Analysis
7. South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2028 – By Cancer Type
7.1 Overview
7.2 South & Central America Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
7.3 Non–Small Cell Lung Cancer (NSCLC)
7.3.1 Overview
7.3.2 Non–Small Cell Lung Cancer (NSCLC): South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Mn)
7.4 Small Cell Lung Cancer
7.4.1 Overview
7.4.2 Small Cell Lung Cancer: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Lung Cancer Screening Market Analysis – by Technology
8.1 Overview
8.2 Low-Dose Computed Tomography (LDCT)
8.2.1 Overview
8.2.2 Low-Dose Computed Tomography (LDCT): South & Central America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
8.3 Chest X-ray
8.3.1 Overview
8.3.2 Chest X-ray: South & Central America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
8.4 Liquid Biopsy
8.4.1 Overview
8.4.2 Liquid Biopsy: South & Central America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: South & Central America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Lung Cancer Screening Market Analysis – by Age Group
9.1 Overview
9.2 & Older
9.2.1 Overview
9.2.2 & Older: South & Central America Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Below 50
9.3.1 Overview
9.3.2 Below 50: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Lung Cancer Screening Market Analysis – by End User
10.1 Overview
10.2 Hospitals
10.2.1 Overview
10.2.2 Hospitals: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
11. South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2028 – Country Analysis
11.1 South & Central America Lung Cancer Screening Market Overview
11.1.1.1 Brazil: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 Brazil: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.1.3 Brazil: South & Central America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.1.4 Brazil: South & Central America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.1.1.1.5 Brazil: South & Central America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.1.6 Brazil: South & Central America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.2 Argentina: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 Argentina: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.3 Argentina: South & Central America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.2.4 Argentina: South & Central America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.5 Argentina: South & Central America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.2.6 Argentina: South & Central America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.3 Rest of South & Central America: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 Rest of South & Central America: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.3 Rest of South & Central America: South & Central America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.3.4 Rest of South & Central America: South & Central America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.5 Rest of South & Central America: South & Central America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.3.6 Rest of South & Central America: South & Central America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
12. South & Central America Lung Cancer Screening Market–Industry Landscape
12.1 Recent Growth Strategies
12.1.1 Overview
13. Company Profiles
13.1 Nuance Communications Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GE HealthCare
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Medtronic
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Canon Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Koninklijke Philips NV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Siemens AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
14. Appendix
14.1 About
14.2 Glossary of Terms

List of Tables

Table 1.             Brazil South & Central America Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 2.             Brazil South & Central America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 3.             Brazil South & Central America Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 4.             Brazil South & Central America Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 5.             Argentina South & Central America Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 6.             Argentina South & Central America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 7.             Argentina South & Central America Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 8.             Argentina South & Central America Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 9.             Rest of South & Central America Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 10.          Rest of South & Central America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 11.          Rest of South & Central America Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 12.          Rest of South & Central America Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 13.          Recent Growth Strategies in the South & Central America Lung Cancer Screening Market
Table 14.          Glossary of Terms
 
 

List of Figures

Figure 1.           South & Central America Lung Cancer Screening Market Segmentation
Figure 2.           South & Central America Lung Cancer Screening Market, by Country
Figure 3.           South & Central America Lung Cancer Screening Market Overview
Figure 4.           Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in South & Central America Lung Cancer Screening Market
Figure 5.           South & Central America Expected to Show Remarkable Growth During Forecast Period
Figure 6.           South & Central America: PEST Analysis
Figure 7.           Experts’ Opinion
Figure 8.           South & Central America Lung Cancer Screening Market Impact Analysis of Driver and Restraints
Figure 9.           South & Central America Lung Cancer Screening Market – Revenue Forecast and Analysis – 2020-2030
Figure 10.        South & Central America Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
Figure 11.        Non–Small Cell Lung Cancer (NSCLC): South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030  (US$ Million)
Figure 12.        Small Cell Lung Cancer: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13.        South & Central America Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)
Figure 14.        Low-Dose Computed Tomography (LDCT): South & Central America Lung Cancer Screening Market– Revenue and Forecast to 2030  (US$ Million)
Figure 15.        Chest X-ray: South & Central America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
Figure 16.        Liquid Biopsy: South & Central America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
Figure 17.        Others: South & Central America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
Figure 18.        South & Central America Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)
Figure 19. & Older: South & Central America Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20.        Below 50: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21.        South & Central America Lung Cancer Screening Market, by End User, 2022 & 2030 (%)
Figure 22.        Hospitals: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23.        Diagnostic Centers: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24.        Others: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25.        South & Central America Lung Cancer Screening Market, by Key Country – Revenue (2022) (US$ Mn)
Figure 26.        South & Central America Lung Cancer Screening Market Revenue Share, by Key Country (2022 and 2030)
Figure 27.        Brazil: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28.        Argentina: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29.        Rest of South & Central America: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

List of Companies

– GE HealthCare Technologies Inc
– Medtronic Plc
– Canon Medical Systems Corp
– Koninklijke Philips NV
– Siemens AG

Reviews

There are no reviews yet.

Be the first to review “South & Central America Lung Cancer Screening Market Forecast to 2030”